CrushSCI.com
107.4平均天数
105.5中位天数
2最短天数
224最长天数
7,1792025发文量

Paper Review Records

全部论文审稿周期

30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

112 天

Cross‐cohort NULISAseq identifies tau‐anchored CSF and plasma‐specific signatures across the amyloid‐positive Alzheimer's disease

作者
Lan Ding; Menghan Zheng; Simiao Wang; Wenying Liu; Yumei Liang; Siqi Xie; Ting Yang; Dandan Sheng; Shuheng Wang; Jianpeng Sheng; Jianping Jia; the Alzheimer's Disease Neuroimaging Initiative展开收起
作者单位
1. Chinese Institutes for Medical Research, Beijing (CIMR) Capital Medical University Beijing P. R. China; 2. Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital Capital Medical University, National Clinical Research Center for Geriatric Diseases Beijing P. R. China; 3. Beijing Key Laboratory of Geriatric Cognitive Disorders Beijing P. R. China; 4. Clinical Center for Neurodegenerative Disease and Memory Impairment Capital Medical University Beijing P. R. China; 5. Center of Alzheimer's Disease Beijing Institute of Brain Disorders Collaborative Innovation Center for Brain Disorders Capital Medical University Beijing P. R. China展开收起
PDF源文件 DOI 网页
130 天

The value of timely treatment with anti‐amyloid therapy for Alzheimer's disease

作者
Jack M. Chapel; Bryan Tysinger; Hossein Pourmand; Dana Goldman; Paul Aisen; for the Alzheimer's Disease Neuroimaging Initiative展开收起
作者单位
1. Sol Price School of Public Policy University of Southern California Los Angeles California USA; 2. Leonard D. Schaeffer Institute for Public Policy and Government Service University of Southern California Los Angeles California USA; 3. Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences University of Southern California Los Angeles California USA; 4. Alzheimer's Therapeutic Research Institute University of Southern California San Diego California USA; 5. Keck School of Medicine University of Southern California Los Angeles California USA展开收起
PDF源文件 DOI 网页
97 天

Cell‐based polygenic risk scores predict clinical progression and prioritize network‐based therapeutic targets in Alzheimer's disease

作者
Nathan Sahelijo; Priya Rajagopalan; Lu Qian; Rufuto Rahman; Daniel Goldstein; Sophia I. Thomopoulos; David A. Bennett; Lindsay A. Farrer; Thor D. Stein; Li Shen; Heng Huang; Kwangsik Nho; Andrew J. Saykin; Christos Davatzikos; Paul M. Thompson; Julia TCW; Gyungah R. Jun展开收起
作者单位
1. Biomedical Genetics Section Department of Medicine Boston University Chobanian and Avedisian School of Medicine Boston Massachusetts USA; 2. Bioinformatics Program Faculty of Computing & Data Sciences Boston University Boston Massachusetts USA; 3. Imaging Genetics Center Mark & Mary Stevens Neuroimaging & Informatics Institute Keck School of Medicine University of Southern California Los Angeles California USA; 4. Department of Neurology Keck School of Medicine University of Southern California Los Angeles California USA; 5. Department of Pharmacology Physiology & Biophysics Boston University Chobanian and Avedisian School of Medicine Boston Massachusetts USA; 6. Rush Alzheimer's Disease Center Rush University Medical Center Chicago Illinois USA; 7. Boston University Alzheimer's Disease Research Center Boston University Chobanian and Avedisian School of Medicine Boston Massachusetts USA; 8. Department of Biostatistics Boston University School of Public Health Boston Massachusetts USA; 9. Department of Epidemiology Boston University School of Public Health Boston Massachusetts USA; 10. Department of Pathology & Laboratory Medicine Boston University School of Medicine Boston Massachusetts USA; 11. VA Bedford Healthcare System Bedford Massachusetts USA; 12. VA Boston Healthcare Center Boston Massachusetts USA; 13. Departments of Biostatistics, Epidemiology, and Informatics University of Pennsylvania School of Medicine Philadelphia Pennsylvania USA; 14. Department of Computer Science University of Maryland College Park College Park Maryland USA; 15. Department of Radiology and Imaging Sciences and Medical and Molecular Genetics Indiana University School of Medicine Indianapolis Indiana USA; 16. Indiana Alzheimer's Disease Research Center Indiana University School of Medicine Indianapolis Indiana USA; 17. Center for Computational Biology and Bioinformatics Indiana University School of Medicine Indianapolis Indiana USA; 18. Department of Radiology University of Pennsylvania School of Medicine Philadelphia Pennsylvania USA展开收起
PDF源文件 DOI 网页
104 天

Structural compression and entorhinal vulnerability: Linking tentorial adjacency to tau burden and dementia progression

作者
Luyue Zhang; Ana M. Franceschi; John F. Crary; Frank A. Provenzano; for the Alzheimer's Disease Neuroimaging Initiative展开收起
作者单位
1. Department of Biomedical Engineering Columbia University New York New York USA; 2. Neuroradiology Division Department of Radiology Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Lenox Hill Hospital New York New York USA; 3. Department of Pathology Nash Family Department of Neuroscience Department of Artificial Intelligence & Human Health Neuropathology Brain Bank & Research CoRE Ronald M. Loeb Center for Alzheimer's Disease Friedman Brain Institute Icahn School of Medicine at Mount Sinai New York New York USA; 4. Department of Neurology Columbia University Irving Medical Center New York New York USA展开收起
PDF源文件 DOI 网页
104 天

Associations between serum estradiol and estrone and Alzheimer's disease biomarkers: An analysis in female participants from the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS)

作者
Juehyun Shin; Graciela Muniz‐Terrera; Craig W. Ritchie; Jean Manson; Susan Plachecki; Clemens Kirschbaum; Sarah Gregory展开收起
作者单位
1. Heritage College of Osteopathic Medicine Ohio University Athens Ohio USA; 2. The Alzheimer's Pathobiome Initiative (AlzPI) Wake Forest North Carolina USA; 3. Scottish Brain Sciences Edinburgh UK; 4. University of St Andrews St Andrews UK; 5. University of Edinburgh Edinburgh UK; 6. Dresden LABservice GmbH Dresden Germany展开收起
PDF源文件 DOI 网页
114 天

More efficient screening for preclinical Alzheimer's clinical trials using mixture of experts

作者
Oliver Langford; Rema Raman; Paul Aisen; Reisa Sperling; Keith Johnson; Doris Molina‐Henry; Pallavi Sachdev; David Li; Gustavo A. Jimenez‐Maggiora; Sterling C. Johnson; Joel B Braunstein; Colin Birkenbihl; Madison Cuppels; Rachel F. Buckley; Robert A. Rissman; Michael C. Donohue展开收起
作者单位
1. Epstein Family Alzheimer's Therapeutic Research Institute, Keck School of Medicine University of Southern California San Diego California USA; 2. Harvard Medical School Brigham and Women's Hospital Massachusetts General Hospital Boston Massachusetts USA; 3. Eisai Inc. Nutley New Jersey USA; 4. School of Medicine and Public Health University of Wisconsin‐Madison Madison Wisconsin USA; 5. C2N Diagnostics St. Louis Missouri USA展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。